Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

Blood

Volumn 93, Issue 9, 1999, Pages 2755-2759

  Faderl, S ^a   Talpaz, M ^a   Kantarjian, H M ^a   Estrov, Z ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC TEST; HEMATOPOIETIC CELL; HUMAN; LEUKEMOGENESIS; MEDICAL DECISION MAKING; MINIMAL RESIDUAL DISEASE; NOTE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033135248     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2755.409a45_2755_2759     Document Type: Note

References (42)